Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
AIDS Research and Human Retroviruses|November 16, 2017
Cytomegalovirus and HIV Persistence: Pouring Gas on the FireAaron Christensen-Quick, Christophe Vanpouille, Andrea Lisco, et al.
Journal of Clinical Apheresis|December 16, 2024
What's in a Name: Your PLEX or PEX Is Our TPEZiver Sahin, Aaron Christensen, Juliana Guarente, et al.
Viruses|May 17, 2017
Human Beta Defensin 2 Selectively Inhibits HIV-1 in Highly Permissive CCR6⁺CD4⁺ T CellsMark K Lafferty, Lingling Sun, Aaron Christensen-Quick, et al.
Journal of Virology|June 24, 2016
Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV InfectionAaron Christensen-Quick, Mark Lafferty, Lingling Sun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2019
Effect of Cannabis Use on Human Immunodeficiency Virus DNA During Suppressive Antiretroviral TherapyAntoine Chaillon, Masato Nakazawa, Christy Anderson, et al.
Diabetes|November 14, 2014
Perilipin 5 regulates islet lipid metabolism and insulin secretion in a cAMP-dependent manner: implication of its role in the postprandial insulin secretionMichelle B Trevino, Yui Machida, Daniel R Hallinger, et al.
Clinical Immunology (Orlando, Fla.)|February 10, 2015
Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organBrian Astry, Shivaprasad H Venkatesha, Arian Laurence, et al.
Journal of Virology|April 26, 2019
Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral TherapyAaron Christensen-Quick, Marta Massanella, Andrew Frick, et al.
NPJ Vaccines|October 15, 2021
INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variantsViviane M Andrade, Aaron Christensen-Quick, Joseph Agnes, et al.
The Journal of Infectious Diseases|January 26, 2022
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label TrialKimberly A Kraynyak, Elliott Blackwood, Joseph Agnes, et al.
Pageof 2